MRIdian Linac Radiation Therapy System Model 10000 and 20000

FDA Device Recall #Z-0676-2020 — Class II — March 3, 2019

Recall Summary

Recall Number Z-0676-2020
Classification Class II — Moderate risk
Date Initiated March 3, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Viewray, Inc.
Location Mountain View, CA
Product Type Devices
Quantity 24 Systems

Product Description

MRIdian Linac Radiation Therapy System Model 10000 and 20000

Reason for Recall

Issue with transferring treatment regiment from one system to another. Adequate instructions for transferring treatment plan(s) are not provided within the operator's manual or within the software operating system.

Distribution Pattern

US - CA, FL, IL, MI, MO, NY, and WI OUS: Denmark, France, Germany, Italy, Japan, Netherlands, Turkey, South Korea, and UAE

Lot / Code Information

Serial Numbers: 100, 101, 102, 103, 104, 105, 107, 108, 112, 113, 201, 202, 203, 204, 205, 206, 209, 211, 213, 214, 217, 221, 223, 225 Device Listing Number: D158423 and D297999

Other Recalls from Viewray, Inc.

Recall # Classification Product Date
Z-1836-2021 Class II ViewRay MRIdian Linac System: Model No. 20000-0... May 4, 2021
Z-0481-2021 Class II ViewRay MRIdian System: Model No. 10000, CE, R... Oct 20, 2020
Z-0482-2021 Class II ViewRay MRIdian Linac System: Model No. 20000,... Oct 20, 2020
Z-1803-2020 Class II ViewRay System: Model No. 10000 and 20000 for r... Nov 18, 2019
Z-1251-2019 Class II MRIdian Linac Radiation Therapy System, Model 2... Mar 18, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.